| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,098 |
2,692 |
$89K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,830 |
2,369 |
$59K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,041 |
1,898 |
$41K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
819 |
736 |
$36K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,146 |
1,229 |
$33K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,271 |
1,171 |
$16K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
876 |
537 |
$10K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
160 |
156 |
$6K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
44 |
41 |
$2K |
| 86308 |
|
181 |
171 |
$723.41 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
28 |
14 |
$178.36 |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
13 |
12 |
$164.34 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
171 |
155 |
$146.25 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
39 |
34 |
$140.72 |
| 81002 |
|
28 |
25 |
$13.57 |